| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 1996;27:2033-2039.)
© 1996 American Heart Association, Inc.
Articles |
Proteinuria Predicts Stroke and Other Atherosclerotic Vascular Disease Events in Nondiabetic and Non–Insulin-Dependent Diabetic Subjects
the Department of Medicine, University of Kuopio (H.M., S.L., K.P., M.L.), the Department of Medicine, University of Turku (T.R.), and the Research and Development Centre, Social Insurance Institution, Turku (T.R.), Finland; and the Department of Medicine, Division of Clinical Epidemiology, University of Texas Health Science Center (San Antonio) (H.M., S.M.H.).
Correspondence to Heikki Miettinen, MD, University of Texas Health Science Center at San Antonio, Department of Medicine, Division of Clinical Epidemiology, 7703 Floyd Curl Dr, San Antonio, TX 78284-7873. E-mail miettine@messi.uku.fi. Reprint requests to Markku Laakso, MD, University of Kuopio, Department of Medicine, PO Box 1627, 70211 Kuopio, Finland.
Background and Purpose Increased urinary albumin and protein excretion is associated with cardiovascular disease mortality independent of other cardiovascular risk factors in subjects with non–insulin-dependent diabetes mellitus (NIDDM). We assessed the relationship between the different degrees of proteinuria at baseline and the incidence of stroke, as well as other atherosclerotic vascular disease events, in a prospective study of nondiabetic and NIDDM subjects.
Methods Our study was based on the 7-year follow-up of cohorts of nondiabetic (n=1375) and NIDDM (n=1056) subjects in Finland. The urinary protein concentration at baseline was stratified into three categories: no proteinuria (<150 mg/L), borderline (150 to 300 mg/L), and clinical proteinuria (>300 mg/L).
Results The association between the different degrees of proteinuria and the atherosclerotic vascular events was similar in nondiabetic and NIDDM subjects. Cardiovascular disease mortality was higher both in nondiabetic and NIDDM subjects with clinical proteinuria than in those without proteinuria. The incidence of stroke was 1.6% in nondiabetic subjects without proteinuria, 3.2% in subjects with borderline proteinuria, and 8.5% in subjects with clinical proteinuria (P<.001 for trend). In NIDDM patients, the corresponding rates were 7.2%, 11.1%, and 23.0%, respectively (P<.001 for trend). The association between clinical proteinuria and the incidence of stroke remained significant both in nondiabetic and in NIDDM subjects after adjustment for other cardiovascular risk factors. Clinical proteinuria was also associated with the incidence of coronary heart disease events and that of lower-extremity amputation. NIDDM independently increased the risk of atherosclerotic vascular disease events regardless of the proteinuria status.
Conclusions Clinical proteinuria significantly predicted stroke and other atherosclerotic vascular disease events independent of other cardiovascular risk factors. This finding is compatible with the view that increased urinary protein excretion rate may be associated with widespread vascular damage.
Key Words: atherosclerosis • coronary heart disease • diabetes mellitus • mortality • proteinuria
This article has been cited by other articles:
 |
|
 |
|
  S. Sheehan, S.-W. Tsaih, B. L. King, C. Stanton, G. A. Churchill, B. Paigen, and K. DiPetrillo Genetic analysis of albuminuria in a cross between C57BL/6J and DBA/2J mice Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1649 - F1656. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Daly Is early chronic kidney disease an important risk factor for cardiovascular disease?: A Background Paper prepared for the UK Consensus Conference on Early Chronic Kidney Disease Nephrol. Dial. Transplant., September 1, 2007; 22(suppl_9): ix19 - ix25. [Full Text] [PDF]
|
|
|
|
 |
|
 Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. V. d. Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur. Heart J. Suppl., June 1, 2007; 9(suppl_C): C3 - C74. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Ingelsson, L. M. Sullivan, J. M. Murabito, C. S. Fox, E. J. Benjamin, J. F. Polak, J. B. Meigs, M. J. Keyes, C. J. O'Donnell, T. J. Wang, et al. Prevalence and Prognostic Impact of Subclinical Cardiovascular Disease in Individuals With the Metabolic Syndrome and Diabetes Diabetes, June 1, 2007; 56(6): 1718 - 1726. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Avogaro, C. Giorda, M. Maggini, E. Mannucci, R. Raschetti, F. Lombardo, S. Spila-Alegiani, S. Turco, M. Velussi, E. Ferrannini, et al. Incidence of Coronary Heart Disease in Type 2 Diabetic Men and Women: Impact of microvascular complications, treatment, and geographic location Diabetes Care, May 1, 2007; 30(5): 1241 - 1247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. B. Giorda, A. Avogaro, M. Maggini, F. Lombardo, E. Mannucci, S. Turco, S. S. Alegiani, R. Raschetti, M. Velussi, E. Ferrannini, et al. Incidence and Risk Factors for Stroke in Type 2 Diabetic Patients: The DAI Study Stroke, April 1, 2007; 38(4): 1154 - 1160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur. Heart J., January 1, 2007; 28(1): 88 - 136. [Full Text] [PDF]
|
|
|
|
|
|
J. L. Carter, C. R. V. Tomson, P. E. Stevens, and E. J. Lamb Does urinary tract infection cause proteinuria or microalbuminuria? A systematic review Nephrol. Dial. Transplant., November 1, 2006; 21(11): 3031 - 3037. [Full Text] [PDF]
|
|
|
|
|
|
G. J. Hankey Potential New Risk Factors for Ischemic Stroke: What Is Their Potential? Stroke, August 1, 2006; 37(8): 2181 - 2188. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Vasan Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations Circulation, May 16, 2006; 113(19): 2335 - 2362. [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Madison, C. Spies, I. J. Schatz, K. Masaki, R. Chen, K. Yano, and J. D. Curb Proteinuria and Risk for Stroke and Coronary Heart Disease During 27 Years of Follow-up: The Honolulu Heart Program. Arch Intern Med, April 24, 2006; 166(8): 884 - 889. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Remuzzi, M. Macia, and P. Ruggenenti Prevention and Treatment of Diabetic Renal Disease in Type 2 Diabetes: The BENEDICT Study J. Am. Soc. Nephrol., April 1, 2006; 17(4_suppl_2): S90 - S97. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Jee, L. E. Boulware, E. Guallar, I. Suh, L. J. Appel, and E. R. Miller III Direct, Progressive Association of Cardiovascular Risk Factors With Incident Proteinuria: Results From the Korea Medical Insurance Corporation (KMIC) Study Arch Intern Med, October 24, 2005; 165(19): 2299 - 2304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. P. Kopyt Slowing Progression Along the Renal Disease Continuum J Am Osteopath Assoc, April 1, 2005; 105(4): 207 - 215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Korstanje and K. DiPetrillo Unraveling the genetics of chronic kidney disease using animal models Am J Physiol Renal Physiol, September 1, 2004; 287(3): F347 - F352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. N. Cohn, A. A. Quyyumi, N. K. Hollenberg, and K. A. Jamerson Surrogate Markers for Cardiovascular Disease: Functional Markers Circulation, June 29, 2004; 109(25_suppl_1): IV-31 - IV-46. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Winer and J. R. Sowers Epidemiology of Diabetes J. Clin. Pharmacol., April 1, 2004; 44(4): 397 - 405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Deferrari, M. Ravera, V. Berruti, G. Leoncini, and L. Deferrari Optimizing Therapy in the Diabetic Patient with Renal Disease: Antihypertensive Treatment J. Am. Soc. Nephrol., January 1, 2004; 15(90010): S6 - 11. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. J. Sarnak, A. S. Levey, A. C. Schoolwerth, J. Coresh, B. Culleton, L. L. Hamm, P. A. McCullough, B. L. Kasiske, E. Kelepouris, M. J. Klag, et al. Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Hypertension, November 1, 2003; 42(5): 1050 - 1065. [Full Text] [PDF]
|
|
|
|
|
|
M. J. Sarnak, A. S. Levey, A. C. Schoolwerth, J. Coresh, B. Culleton, L. L. Hamm, P. A. McCullough, B. L. Kasiske, E. Kelepouris, M. J. Klag, et al. Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Circulation, October 28, 2003; 108(17): 2154 - 2169. [Full Text] [PDF]
|
|
|
|
|
|
G. Leoncini, F. Viazzi, D. Parodi, S. Vettoretti, E. Ratto, M. Ravera, C. Tomolillo, M. Del Sette, G. P. Bezante, G. Deferrari, et al. Mild Renal Dysfunction and Subclinical Cardiovascular Damage in Primary Hypertension Hypertension, July 1, 2003; 42(1): 14 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Nakajima, Y. Tanaka, T. Nomiyama, T. Ogihara, F. Ikeda, R. Kanno, N. Iwashita, K. Sakai, H. Watada, T. Onuma, et al. RANTES Promoter Genotype Is Associated With Diabetic Nephropathy in Type 2 Diabetic Subjects Diabetes Care, March 1, 2003; 26(3): 892 - 898. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Sowers and S. Haffner Treatment of Cardiovascular and Renal Risk Factors in the Diabetic Hypertensive Hypertension, December 1, 2002; 40(6): 781 - 788. [Full Text] [PDF]
|
|
|
|
|
|
A. N. Friedman, L. G. Hunsicker, J. Selhub, A. G. Bostom, and The Collaborative Study Group Proteinuria as a Predictor of Total Plasma Homocysteine Levels in Type 2 Diabetic Nephropathy Diabetes Care, November 1, 2002; 25(11): 2037 - 2041. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Deferrari, M. Ravera, L. Deferrari, S. Vettoretti, E. Ratto, and D. Parodi Renal and Cardiovascular Protection in Type 2 Diabetes Mellitus: Angiotensin II Receptor Blockers J. Am. Soc. Nephrol., November 1, 2002; 13(90003): S224 - 229. [Abstract] [Full Text]
|
|
|
|
|
|
P. W. de Leeuw, L. Thijs, W. H. Birkenhager, S. M. Voyaki, A. D. Efstratopoulos, R. H. Fagard, G. Leonetti, C. Nachev, J. C. Petrie, J. L. Rodicio, et al. Prognostic Significance of Renal Function in Elderly Patients with Isolated Systolic Hypertension: Results from the Syst-Eur Trial J. Am. Soc. Nephrol., September 1, 2002; 13(9): 2213 - 2222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Matsumoto, E. Ishimura, H. Taniwaki, M. Emoto, T. Shoji, T. Kawagishi, M. Inaba, and Y. Nishizawa Smoking and proteinuria impair vasodilatory response of intrarenal arteries to nitroglycerine in patients with type 2 diabetes mellitus Nephrol. Dial. Transplant., April 1, 2002; 17(4): 608 - 613. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Caro, A. J. Ward, and J. A. O'Brien Lifetime Costs of Complications Resulting From Type 2 Diabetes in the U.S. Diabetes Care, March 1, 2002; 25(3): 476 - 481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Guerrero-Romero and M. Rodriguez-Moran Proteinuria Is an Independent Risk Factor for Ischemic Stroke in Non–Insulin-Dependent Diabetes Mellitus Stroke, September 1, 1999; 30(9): 1787 - 1791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. E. Davis, H. Millns, I. M. Stratton, R. R. Holman, R. C. Turner, and for the UK Prospective Diabetes Study Group Risk Factors for Stroke in Type 2 Diabetes Mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29 Arch Intern Med, May 24, 1999; 159(10): 1097 - 1103. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Streja and S. W. Rabkin Factors Associated With Implementation of Preventive Care Measures in Patients With Diabetes Mellitus Arch Intern Med, February 8, 1999; 159(3): 294 - 302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. A. Blezer, M. Schurink, K. Nicolay, P. R. D. Bar, G. H. Jansen, H. A. Koomans, J. A. Joles, and W. G. Mayhan Proteinuria Precedes Cerebral Edema in Stroke-Prone Rats : A Magnetic Resonance Imaging Study • Editorial Comment: A Magnetic Resonance Imaging Study Stroke, January 1, 1998; 29(1): 167 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Mosca, J. E. Manson, S. E. Sutherland, R. D. Langer, T. Manolio, E. Barrett-Connor, and E. Barrett-Connor Cardiovascular Disease in Women : A Statement for Healthcare Professionals From the American Heart Association Circulation, October 7, 1997; 96(7): 2468 - 2482. [Full Text]
|
|